R L Watts

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. pmc The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    Jeanne C Latourelle
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
    BMC Med 6:32. 2008
  2. doi request reprint Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
    Ray L Watts
    Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294 0017, USA
    Mov Disord 25:858-66. 2010
  3. ncbi request reprint Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
    R L Watts
    Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35233 0017, USA
    Neurology 68:272-6. 2007
  4. ncbi request reprint Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome
    D L Bliwise
    Department of Neurology, Emory University Medical School, WMRB, Suite 6000, 1639 Pierce Drive, Atlanta, GA 30322, USA
    Sleep Med 6:141-7. 2005
  5. ncbi request reprint Genome-wide scan for Parkinson's disease: the GenePD Study
    A L DeStefano
    Department of Neurology, Boston University Schools of Medicine and of Public Health, Boston, MA 02118, USA
    Neurology 57:1124-6. 2001
  6. ncbi request reprint Ophthalmologic features of Parkinson's disease
    V Biousse
    Department of Ophthalmology, Emory University, Atlanta, USA
    Neurology 62:177-80. 2004
  7. ncbi request reprint Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease
    J M van der Walt
    Department of Medicine and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA
    Neurology 60:1189-91. 2003
  8. ncbi request reprint Occupation and parkinsonism in three movement disorders clinics
    S M Goldman
    The University of California, San Francisco, CA, USA
    Neurology 65:1430-5. 2005
  9. ncbi request reprint Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease
    E R Martin
    Center for Human Genetics, Box 2903, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 286:2245-50. 2001
  10. ncbi request reprint Complete genomic screen in Parkinson disease: evidence for multiple genes
    W K Scott
    Center for Human Genetics, Box 3445, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 286:2239-44. 2001

Collaborators

Detail Information

Publications10

  1. pmc The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
    Jeanne C Latourelle
    Department of Neurology, Boston University School of Medicine, Boston University, Boston, MA, USA
    BMC Med 6:32. 2008
    ..Studies of the penetrance of LRRK2 mutations have produced a wide range of estimates, possibly due to differences in study design and recruitment, including in particular differences between samples of familial PD versus sporadic PD...
  2. doi request reprint Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
    Ray L Watts
    Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294 0017, USA
    Mov Disord 25:858-66. 2010
    ..Ropinirole prolonged-release delayed the onset of dyskinesia with comparable efficacy to increased doses of levodopa in early PD patients not optimally controlled with levodopa...
  3. ncbi request reprint Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
    R L Watts
    Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35233 0017, USA
    Neurology 68:272-6. 2007
    ....
  4. ncbi request reprint Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome
    D L Bliwise
    Department of Neurology, Emory University Medical School, WMRB, Suite 6000, 1639 Pierce Drive, Atlanta, GA 30322, USA
    Sleep Med 6:141-7. 2005
    ..The purpose of this study was to test the clinical efficacy of ropinirole, a D2/D3 agonist, in the treatment of RLS in a double-blind, short-term, placebo-controlled clinical trial...
  5. ncbi request reprint Genome-wide scan for Parkinson's disease: the GenePD Study
    A L DeStefano
    Department of Neurology, Boston University Schools of Medicine and of Public Health, Boston, MA 02118, USA
    Neurology 57:1124-6. 2001
    ..The chromosome 9 region overlaps the genes for dopamine beta-hydroxylase and torsion dystonia. Although no strong evidence for linkage was found for any locus, these results may be of value in comparison with similar studies by others...
  6. ncbi request reprint Ophthalmologic features of Parkinson's disease
    V Biousse
    Department of Ophthalmology, Emory University, Atlanta, USA
    Neurology 62:177-80. 2004
    ..These findings likely account for many of the visual difficulties commonly encountered by PD patients. These ocular abnormalities frequently respond to treatment...
  7. ncbi request reprint Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease
    J M van der Walt
    Department of Medicine and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA
    Neurology 60:1189-91. 2003
    ..The authors did not find evidence for association with increased risk for PD between any individual NAT1 or NAT2 SNP or acetylation haplotype (N = 397 families, 1,580 individuals)...
  8. ncbi request reprint Occupation and parkinsonism in three movement disorders clinics
    S M Goldman
    The University of California, San Francisco, CA, USA
    Neurology 65:1430-5. 2005
    ..The aim of the present study was to investigate occupational associations with PD or parkinsonism drawing from three different movement disorders clinics...
  9. ncbi request reprint Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease
    E R Martin
    Center for Human Genetics, Box 2903, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 286:2245-50. 2001
    ..001) was detected between 4 of the 5 SNPs (SNPs 3, 9i, 9ii, and 11). CONCLUSIONS: This integrated approach of genetic linkage and positional association analyses implicates tau as a susceptibility gene for idiopathic PD...
  10. ncbi request reprint Complete genomic screen in Parkinson disease: evidence for multiple genes
    W K Scott
    Center for Human Genetics, Box 3445, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 286:2239-44. 2001
    ..CONCLUSIONS: Our data suggest that the parkin gene is important in early-onset PD and that multiple genetic factors may be important in the development of idiopathic late-onset PD...